Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,379 | 578 | 840 | 748 | 1,109 |
| Receivables | 560 | 12,480 | 4,435 | 4,934 | 1,149 |
| Inventories | 1,890 | 1,129 | 1,684 | 1,906 | 2,263 |
| TOTAL | $6,056 | $15,284 | $7,918 | $8,970 | $5,873 |
| Non-Current Assets | |||||
| PPE Net | 416 | 418 | 420 | 424 | 429 |
| Intangibles | 778 | 4,348 | 5,238 | 4,738 | 6,487 |
| Other Non-Current Assets | 192 | 224 | 231 | 250 | 88 |
| TOTAL | $1,386 | $4,990 | $5,889 | $5,412 | $7,004 |
| Total Assets | $7,442 | $20,274 | $13,807 | $14,382 | $12,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 147 | 291 | 383 | N/A |
| Accounts payable and accrued liabilities | 12,003 | 13,153 | 11,624 | 12,291 | 11,224 |
| Accrued Expenses | 2,700 | 3,879 | 4,972 | 6,576 | 5,888 |
| Other current liabilities | 11,619 | 13,294 | 9,516 | 7,805 | 8,021 |
| TOTAL | $78,752 | $84,820 | $78,186 | $73,893 | $70,854 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,402 | 4,891 | 5,790 | 5,319 | 6,825 |
| TOTAL | $1,402 | $4,891 | $5,790 | $5,319 | $6,825 |
| Total Liabilities | $80,154 | $89,711 | $83,976 | $79,212 | $77,679 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 132,530 | 132,530 | 126,686 | 118,656 | 113,356 |
| Common Shares | 13 | 13 | 12 | 12 | 11 |
| Retained earnings | -902,875 | -897,390 | -900,176 | -898,496 | -896,711 |
| Other shareholders' equity | -1,725 | -3,919 | -1,821 | 2,230 | 2,802 |
| TOTAL | $-72,712 | $-69,437 | $-70,169 | $-64,830 | $-64,802 |
| Total Liabilities And Equity | $7,442 | $20,274 | $13,807 | $14,382 | $12,877 |